Healthcare provider profile · identity verified

Christopher Ryan Young, M.D.

Family Practice · ELK GROVE, CA · NPI 1245670009

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	537	163
Amlodipine Besylate	Amlodipine Besylate	413	112
Losartan Potassium	Losartan Potassium	329	90
Lisinopril	Lisinopril	286	78
Gabapentin	Gabapentin	222	59
Tamsulosin Hcl	Tamsulosin Hcl	207	57
Levothyroxine Sodium	Levothyroxine Sodium	193	55
Simvastatin	Simvastatin	178	43
Pantoprazole Sodium	Pantoprazole Sodium	174	54
Metformin Hcl Er	Metformin Hcl	160	43
Fluticasone Propionate	Fluticasone Propionate	158	63
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	157	38
Albuterol Sulfate Hfa	Albuterol Sulfate	148	47
Omeprazole	Omeprazole	147	47
Metformin Hcl	Metformin Hcl	136	38
Metoprolol Succinate	Metoprolol Succinate	119	34
Trazodone Hcl	Trazodone Hcl	115	34
Eliquis	Apixaban	105	23
Metoprolol Tartrate	Metoprolol Tartrate	103	28
Rosuvastatin Calcium	Rosuvastatin Calcium	91	33
Hydrochlorothiazide	Hydrochlorothiazide	90	27
Benazepril Hcl	Benazepril Hcl	83	22
Furosemide	Furosemide	76	21
Ozempic	Semaglutide	76	14
Sertraline Hcl	Sertraline Hcl	74	20
Duloxetine Hcl	Duloxetine Hcl	69	20
Potassium Chloride	Potassium Chloride	68	22
Montelukast Sodium	Montelukast Sodium	65	18
Diclofenac Sodium	Diclofenac Sodium	63	21
Ezetimibe	Ezetimibe	60	16
Tramadol Hcl	Tramadol Hcl	58	13
Escitalopram Oxalate	Escitalopram Oxalate	53	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	53	15
Triamcinolone Acetonide	Triamcinolone Acetonide	49	25
Atenolol	Atenolol	48	11
Mirtazapine	Mirtazapine	48	15
Zolpidem Tartrate	Zolpidem Tartrate	48	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	11
Clopidogrel	Clopidogrel Bisulfate	45	14
Quetiapine Fumarate	Quetiapine Fumarate	44	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	44	suppressed
Glipizide Er	Glipizide	42	13
Alprazolam	Alprazolam	39	18
Clonazepam	Clonazepam	38	suppressed
Azelastine Hcl	Azelastine Hcl	36	15
Allopurinol	Allopurinol	35	12
Alendronate Sodium	Alendronate Sodium	34	suppressed
Carvedilol	Carvedilol	34	13
Diazepam	Diazepam	34	13
Pravastatin Sodium	Pravastatin Sodium	34	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	34	suppressed
Tizanidine Hcl	Tizanidine Hcl	34	19
Glipizide	Glipizide	33	11
Farxiga	Dapagliflozin Propanediol	31	suppressed
Bupropion Xl	Bupropion Hcl	30	suppressed
Lidocaine	Lidocaine	30	suppressed
Celecoxib	Celecoxib	29	suppressed
Chlorthalidone	Chlorthalidone	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	29	suppressed
Prednisone	Prednisone	29	13
Januvia	Sitagliptin Phosphate	28	suppressed
Jardiance	Empagliflozin	28	suppressed
Meloxicam	Meloxicam	27	suppressed
Famotidine	Famotidine	26	suppressed
Myrbetriq	Mirabegron	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Ketoconazole	Ketoconazole	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Finasteride	Finasteride	22	suppressed
Ibuprofen	Ibuprofen	22	11
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	15
Mounjaro	Tirzepatide	21	suppressed
Spiriva Respimat	Tiotropium Bromide	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	11
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Azithromycin	Azithromycin	14	14
Baclofen	Baclofen	14	suppressed
Eszopiclone	Eszopiclone	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Naproxen	Naproxen	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Estradiol	Estradiol	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	12
Verapamil Er	Verapamil Hcl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Cephalexin	Cephalexin	12	12
Fentanyl	Fentanyl	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Sumatriptan	Sumatriptan	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error